Cannabis

2040 posts
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
File image of a snow drift

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Some shareholders have enjoyed early holiday gifts in the form of rising stock prices, while others have faced disappointments.
Organigram cannabis operation

Organigram becomes Canada’s largest cannabis company

Organigram (TSX:OGI) acquires Motif Labs for up to $100M, making it the largest Canadian cannabis company by market share at 12.4 per cent.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Bud, brews and balance sheets

Canopy Growth launched two holiday-themed cannabis products from Tweed, including a sugar-free cranberry ginger ale (10 mg THC) and...
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.
The Luz Maria copper prospect on Western Metallica Resources' Caña Brava project in Peru

Three micro-cap value stocks trading at peak pessimism

When it comes to micro-cap value stocks, investors with the sturdiest stomachs tend to prevail regardless of due diligence.
AI generated stock image

Buzz on the Bullboards: Stocks to watch in volatile times.

The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace.
The Good Shroom Company logo

This micro-cap cannabis stock turned its first yearly profit

The Good Shroom Co. (TSXV:MUSH), an emerging micro-cap cannabis stock, is announcing its first fully profitable fiscal year.
Canopy Growth's incoming CEO Luc Mongeau

Meet Canopy Growth’s new CEO, Luc Mongeau

Canopy Growth (TSX:WEED) names board member Luc Mongeau as its next chief executive officer (CEO) effective January 6, 2025.
Image via Cannara Biotech Inc.

Cannara reports record growth and profitability in Q4 2023

Cannara Biotech Inc. (TSXV:LOVE) reported record growth and profitability in it Q4 and 2024 fiscal year results.
Green Thumb's incredibles cannabis gummies

Profitable cannabis stock Green Thumb opens 100th dispensary

Profitable cannabis stock Green Thumb Industries (CSE:GTII) surpasses 100 retail locations in the United States.
Stock Talk Cannabis Report image of cannabis plants and VW van

The Market Online’s Weekly Cannabis Report – Nov. 22, 2024

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.
Lightspeed Introduces the Next Generation Kitchen Display System (CNW Group Lightspeed Commerce Inc.

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
Claybourne infused cannabis prerolls

Canopy Growth brings award-winning Claybourne brand to Canada

Canopy Growth (TSX:WEED) launches the award-winning California-grown Claybourne brand in Canada through an exclusive licensing agreement.
Cannabis Report text across cannabis leaves.

The Market Online’s Weekly Cannabis Report – Nov. 15, 2024

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.
AI generated stock image

Buzz on the Bullboards: TSX hits new high amid holiday optimism and sector disparities

This past week, the TSX reached a new intraday high, reflecting a buoyant market sentiment as investors gear up for the holiday season.
Cybin - CEO, Doug Drysdale (first from left).

Cybin launches new program phase to treat Major Depressive Disorder

Cybin (Cboe CA:CYBN) began its Phase 3 PARADIGM program to evaluate the efficacy of CYB003 to treat Major Depressive Disorder (MDD).